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Interindividual variation in neurovascular reserve and its relationship with cognitive performance is not
well understood in imaging in neurodegeneration. We assessed the neurovascular reserve in amnestic
mild cognitive impairment (aMCI) and Alzheimer’s dementia (AD). Twenty-eight healthy controls (HC),
15 aMCI, and 20 AD patients underwent blood oxygen leveledependent imaging for 9 minutes, breathing
alternatively air and 7% carbon dioxide mixture. The data were parcellated into 88 anatomic regions, and
carbon dioxide regressors accounting for different washin and washout velocities were ﬁtted to regional
average blood oxygen leveledependent signals. Velocity of cerebrovascular reactivity (CVR) was analyzed
and correlated with cognitive scores. aMCI and AD patients had signiﬁcantly slower response than HC
(mean time to reach 90% of peak: HC 33 seconds, aMCI and AD 59 seconds). CVR velocity correlated with
Mini Mental State Examination in 35 of 88 brain regions (p ¼ 0.019, corrected for multiple comparisons),
including 10 regions of the default-mode network, an effect modulated by age. This easily applicable
protocol yielded a practical assessment of CVR in cognitive decline.
 2015 Elsevier Inc. All rights reserved.1. Introduction
Vascular alterations are present in several dementias, including
Alzheimer’s disease (AD) and can appear at an early stage (Claassen
et al., 2009). Through neurovascular coupling, vascular alterations
can cause changes in cognitive performance (Novak and Hajjar,
2010). This interaction is made more complex by interindividual
variation in cognitive reserve (Stern, 2012), which modulates the
relationship between cognitive function and structural damage
(magnetic resonance imaging, MRI) or impaired metabolism
(positron emission tomography) (Fotenos et al., 2008; Garibottoque et neuro-interventionnel
brielle Perret-Gentil 4, 1211
x: þ41 (0) 22 37 27072.
ll rights reserved.et al., 2008). To shed light on the complex interplay between
cognitive performance and neurovascular reserve, a better under-
standing of the link between cognitive deﬁcits and brain pathology
in the transition from healthy control subjects (HC) to amnestic
mild cognitive impairment (aMCI) to AD could be provided by
determining if alterations in cerebrovascular reserve, which can be
assessed via a measurement of cerebrovascular reactivity (CVR), are
linked to alterations in cognition.
The application of carbon dioxide (CO2) induces vasodilation,
which can be assessed in the entire brain parenchyma using blood
oxygen leveledependent (BOLD) MRI (Cohen et al., 2002; Haller
et al., 2006, 2008; Kassner and Roberts, 2004; Mutch et al., 2012;
Ziyeh et al., 2005). Beyond changes in CVR amplitude, 1 previous
functional magnetic resonance imaging (fMRI) study (Cantin et al.,
2011) observed that a different slope of response to hypercapnia
was found in MCI and AD patients than in control subjects,
J. Richiardi et al. / Neurobiology of Aging 36 (2015) 33e4134suggesting that the temporal dynamics of CVR may differ. In that
study, however, the spatial distribution of these changes in timing
was not studied, andno relationship between cognition and velocity
wasestablished.Other studies suggest that changes in the amplitude
of CVR in AD is widely distributed across the brain: impaired CVR in
frontal, parietal, and temporal lobes has been found using CT (Oishi
et al., 1999), and BOLD-MRI studies (Cantin et al., 2011; Yezhuvath
et al., 2012) showing that large-scale vascular changes are occur-
ring with the disease. Coherently, resting-state BOLD fMRI in-
vestigations also demonstrated large-scale functional network
alterations in dementia (Greicius et al., 2004), suggesting that
studying regional changes across the whole brain yields additional
insights into the spatial localization of differences between patients
and control subjects. An additional motivation for studying changes
at the regional level is that, in healthy control subjects at least, CVR is
very regionally speciﬁc (Rostrup et al., 2000).
The current investigation tested the hypothesis that aMCI and
AD patients exhibit abnormal vascular CVR dynamics, and that
these abnormalities are related to cognition. To this end, we
assessed the velocity of the regional CVR during a CO2 challenge in
aMCI and AD compared with healthy control subjects.
2. Methods
2.1. Subjects
The local ethical committee approved this prospective study; all
participants gave written informed consent before inclusion. From
our memory clinic, 63 subjects were prospectively included,
including 20 AD patients, 15 aMCI patients, and 28 HC from the
Basel Study on the Elderly (Monsch and Kressig, 2010). Groups were
relatively well balanced for sex and age (Table 1) showing no sig-
niﬁcant differences. AD patients had lower Mini Mental State Ex-
amination (MMSE) scores but generally were minimally impaired.
The subjects were examined according to standard diagnostic
procedures (Monsch and Kressig, 2010), including brain MRI
without contrast agents. The diagnosis criteria for AD were based
on the NINCDS-ADRDA criteria (McKhann et al., 1984). The diag-
nosis criteria for aMCI were based on Winblad et al. (2004).
2.2. Magnetic resonance imaging
Imaging was performed on a 3T clinical whole-body MRI scan-
ner (Verio, Siemens Medical Systems, Erlangen, Germany). Stan-
dard routine clinical imaging included a 3D T1w (1 mm3 isotropic,
256  256  176 matrix). Additional sequences (T1w, T2w, T2*, and
FLAIR) were acquired and analyzed to exclude brain pathology suchTable 1
Demographic information
HC aMCI AD
Number of subjects 28 15 20
Number of women (percentage)a 18 (64) 9 (60) 10 (50)
Average age (y)  SDb 73  7 71  10 76  7
Mean MMSE score  SDc 29  1 28  2 25  3
Median Fazekas score (range)d 1 (0e3) 1 (0e3) 1 (0e3)
Continuous measures are compared between groups using a 1-way ANOVA.
Dichotomous variables: c2 test. Ordinal measures: Kruskal-Wallis test.
Key: AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; ANOVA,
analysis of variance; HC, healthy controls; MMSE, Mini Mental State Examination;
SD: standard deviation.
a No signiﬁcant difference between groups (c2 ¼ 1.0, p ¼ 0.61).
b No signiﬁcant difference between groups (F ¼ 1.9, p ¼ 0.16).
c Signiﬁcant difference between groups (F ¼ 31.9, p < 109), no difference be-
tween HC and aMCI.
d No signiﬁcant difference between groups (c2 ¼ 0.12, p ¼ 0.94).as ischemic stroke, subdural hematomas, or space-occupying le-
sions and determine white matter lesion severity (Fazekas et al.,
1987), Table 1.
The 9minutes CO2 challenge consisted of CO2 administered via a
nasal cannula in a concentration of 7% mixed in synthetic air, with
the sequence 1minute OFF, 2 minutes ON, 2 minutes OFF, 2 minutes
ON, 2 minutes OFF (details in the following). Subjects were asked to
breathe normally through the nose. Simultaneous multi-echo echo-
planar imaging (EPI) covering the entire brain was acquired with
the following parameters: 64  48 matrix, 34 slices, voxel size of
3.44  3.44  3.5 mm3, echo times of 12.3, 29.5, 46.8, and 64 ms,
repetition time of 2970 ms, 180 repetitions.
We deliberately chose a very simple experimental setup, con-
sisting of a gas bottle with a ready for use mix of 7% CO2 and syn-
thetic air. This gas bottle was outside the MRI in the control room
and connected via a simple silicone tube to a standard nasal can-
nula in the MRI room. The technician manually started and stopped
the CO2 application at 8 L/min using a standard clinical ﬂow meter.
Note that much more sophisticated setups exist including auto-
matic synchronization with the MRI sequence and use of tight face
masks to segregate inﬂow and outﬂow with the ability to measure
expiratory CO2 concentration. Such a setup is in our experience the
most appropriate for a research setting in younger individuals, as
for example tight face masks are oftentimes not well tolerated by
elderly individuals.
2.3. Preprocessing
Datawere preprocessed using SPM8 (version 5236, http://ﬁl.ion.
ucl.ac.uk/spm/). For BOLD analysis, the second echo of the EPI
sequence was used. Functional images were motion corrected
(realignment to the mean image). The T1w structural image was
segmented and normalized (“new segment” algorithm). Functional
images were coregistered to the normalized T1w structural image.
The structural images were parcellated into 90 cortical and subcor-
tical graymatter regions using the AAL atlas (Tzourio-Mazoyer et al.,
2002). The bilateral globus pallidus was removed from the data
because of characteristic segmentation issues related to its small size
in the atlas, leaving 88 regions. EPI data were averaged within each
atlas region, yielding 88 regionally averaged time series per subject
with improved signal-to-noise ratio compared with individual
voxelwise data. Each time series was rescaled by the grand mean
computed over all atlas regions of the corresponding subject and
linearly detrended. The 6 translation and rotation parameters from
the realignment procedure were regressed out. Finally, each time
course was Winsorized to the 5th and 95th percentile to minimize
the effect of any remaining intensity spikes.
For voxel-based morphometry (VBM) analysis, the VBM8
toolbox (http://dbm.neuro.uni-jena.de/vbm/) was used. T1w im-
ages were normalized toMNI space (DARTEL warping, default ICBM
template). The resulting normalized gray matter segments were
modulated to account for spatial normalization. The data were
smoothed by convolution with an 8 mm-FWHM Gaussian kernel.
2.4. Statistical analyses
Analyses were performed usingMatlab R2012b and the statistics
and optimization toolboxes version R2012b (Mathworks, Natick,
MA, USA), as well as R 3.0.2 with the stats 3.0.2, nlme 3.1-113, car
2.0-19, multcomp 1.3-1, and effects 2.3 packages (R Foundation for
Statistical Computing, Vienna, Austria).
2.4.1. VBM analysis
For visual quality assurance of the homogeneity of the data, the
sample covariance matrix was displayed, as well as 1 slice per
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normalized, modulated individual gray matter volumes as pre-
dictors, and a categorical ternary group membership variable (HC,
MCI, or AD) as a covariate. The model parameters were estimated,
and pairwise contrasts (HC > MCI, HC > AD, and MCI > AD) were
computed. Multiple comparison correction was applied using
familywise error rate (FWER).
2.4.2. CVR analysis
Studies of hypercapnia typically use end-tidal CO2 time courses
measured in vivo as a regressor for the BOLD signal (Cantin et al.,
2011). In our setup, no end-tidal CO2 levels are monitored, and
the regressors are therefore deﬁned analytically. A CO2 challenge
regressor was deﬁned by convolving the CO2 on-off timing vector
with a ﬁlter whose frequency response is given as:
HðuÞ ¼ c
1 þ ð1  cÞe u
where c is a constant, leading to an exponential washin and
washout behavior (see Fig. 1). c was set to 0.15, to obtain a shape
similar to previous work (Jiang et al., 2010; Rieger et al., 2012;
Stefanovic et al., 2006) (see Fig. 3 e.g., ﬁts). Note that in Jiang
et al. (2010) a similar regressor was obtained by convolving the
CO2 timing vector with a gamma function, also exhibiting theFig. 1. Model regressors for CO2 challenge. Time courses of the “nominal” (continuous line)
before orthogonalization, whereas the bottom panel shows them as entered in the designexponential behavior. We denote that the “nominal” CO2 regressor,
meaning that it represents the expected response in healthy sub-
jects, based on the literature. A second CO2 regressor with c ¼ 0.11
was computed, representing a slower vessel dilation and lower
slope during the steady-state phase of hypercapnia (Cantin et al.,
2011). This was denoted as the “slow” CO2 regressor. Linear com-
binations of these regressors give rise to a ﬂexible family of possible
BOLD response time courses, representing the various possible
dynamics of the CVR. Regressors were shifted by 1 repetition time
(3 seconds) to account for hemodynamic lag. The 2 regressors were
normalized to unit peak-to-peak amplitude, demeaned, and
orthogonalized (Fig. 1). The principle of using linear combinations
of regressors to obtain a more ﬂexible temporal representation is
similar to adding temporal derivative to the canonical hemody-
namic response function (Friston et al., 1998), except that in our
case the effect of adding the “slow” regressor is to modify slopes of
the washin and washout, instead of shifting the basis functions
forward or backward (note also that the “slow” regressor is not the
derivative of the “nominal” regressor).
Two CO2 regression coefﬁcients (denoted b1, b2) were estimated
per region (88 per subject) using constrained least squares ﬁtting
(Matlab function lsqlin), imposing positivity of the b1 coefﬁcient to
ensure physiological plausibility of the linear combination of re-
gressors. A negative b2 value corresponds to a slower response thanand “slow” (dashed line) CO2 challenge regressors. The top panel shows the regressors
matrix.
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corresponds to a faster response. Thus, b2 models CVR velocity
(representing the rate of vasodilation or vasoconstriction, and
controlling the initial slope of the washin and washout periods),
whereas b1 models amplitude. Showing a correspondence with the
sigmoid conceptual model relating blood ﬂow change to partial
pressure of CO2 (Sobczyk et al., 2014), a Gompertz sigmoid function
can be ﬁt to our linear combination of regressors with very high
goodness of ﬁt (R2 around 0.99), and the b2 parameter has a clear
inﬂuence on the Gompertz growth rate parameter. Each regionwas
subsequently represented by its b1 or b2 CVR coefﬁcient value in
second-level analyses. Model ﬁt was assessed by an F-test.
Four main analyses were performed: (1) overall effect; (2) lobe
level; (3) regional level; and ﬁnally; (4) relationship between CVR
parameters and cognitive scores. For the overall analysis, a 3-way
mixed-effects ANOVA with diagnostic group and lobe as main ef-
fects, subject as random effect, and subject nested in group was
conducted on the b1 and b2 values, via a linear mixed model.
Comparisons on group effect were performed using the Benjamini-
Hochberg step-down procedure (FDR) to adjust the reported p-
value for multiple comparisons (Benjamini and Hochberg, 1995). In
lobe-level analysis, to yield insights into the spatial location of
differences and enable comparisonwith the literature (Cantin et al.,
2011), brain regions were grouped into 7 lobes (Tzourio-Mazoyer
et al., 2002), and the data for each lobe were modeled using a
separate linear mixed-effect model, with group as main effect,
subject as random effect, and subject nested in group. Tukey con-
trasts (HC> aMCI, HC> AD, and aMCI> AD) were computed for the
main effect of group in each model. Within each pairwise contrast,
the uncorrected p-values were compared with a signiﬁcance
threshold FDR-adjusted for the number of lobes. For the region-
level analysis, pairwise contrasts were computed between diag-
nostic groups for all 88 regions, using a 1-sided 2-sample t test
assuming unequal variance, and results were FDR corrected. In
addition, a receiver operating characteristic analysis was performed
for each region, using 1000 bootstrap replicates to compute a
conﬁdence interval on the area under curve. The relationship be-
tween CVR coefﬁcients and any residual motion was tested by a
linear mixed model regressing the CVR velocity or amplitude co-
efﬁcient on 12 summary motion parameters (average and
maximum x, y, z translations, and pitch, roll, and yaw rotations for
each subject), with subject as random effect, and subject nested in
group. The relationship between CVR coefﬁcients and global gray
matter atrophy was tested by a linear mixed model regressing the
CVR velocity or amplitude coefﬁcient on gray matter volume (ob-
tained from VBM analysis), with subject as random effect, and
subject nested in group. We also tested the relationship between
CVR coefﬁcients and microangiopathy by performing the same
analysis as for gray matter volume, but with Fazekas scores.
Finally, the relationship between CVR coefﬁcients and cognitive
scores was modeled at the regional level by the full cognitive model
b2¼ 1þ genderþ ageþMMSEþ age:MMSE. A baseline model b2¼
1 þ gender þ age was also used for comparison. Model ﬁt was
assessed by F-test. Effect plots were computed (R effects package).
3. Results
3.1. Structural voxelwise analysis
No subjects were excluded after quality assurance. VBM analysis
showed no signiﬁcant difference between HC and aMCI groups (a¼
0.05, FWER corrected) in graymatter density. The AD group showed
a few locations with signiﬁcant gray matter reductions (p < 0.05
FWER, peak T-value 8.62) including the hippocampal formation, as
well as in the right medial temporal gyrus, right superior temporalgyrus, and left uncus and left amygdala. Also compared with aMCI,
the AD group had signiﬁcant gray matter density reductions (p <
0.05 FWER, peak T-value 6.28), located in the left parahippocampal
area and with smaller spatial extent. There were no differences
between HC and aMCI in gray matter density. As shown below
(region-level analysis), areas of reduced gray matter density in VBM
do not correspond to regions that have a trend for differences in
CVR velocity.
3.2. CVR analysis
3.2.1. Overall analysis
Subjects reported no discomfort during MR imaging and CO2
administration.
There was a signiﬁcant main effect of group (c2 ¼ 6.09, p ¼
0.048) and lobe (c2 ¼ 85.76, p < 1015) on CVR velocity. There was
no signiﬁcant effect of group on CVR amplitude (c2 ¼ 1.02, p ¼
0.600) but a signiﬁcant effect of lobe (c2 ¼ 817.68, p < 1015). CVR
velocity was signiﬁcantly larger in control subjects than in aMCI
(z ¼ 1.03, p ¼ 0.034 FDR) and AD patients (z ¼ 0.99, p ¼ 0.034 FDR).
Control subjects (HC) had a positive group mean CVR velocity
(mean and standard error: 0.77  0.03), whereas patients had a
negative group mean CVR velocity (aMCI: 0.26  0.06, AD:0.22
 0.06), indicating that CVR in control subjects was on average
faster than the nominal response, whereas CVR in patients was
slower than nominal. These values correspond to a mean time to
reach 90% of peak response of 33 seconds for HC and 59 seconds for
aMCI and AD. There was no signiﬁcant difference in CVR velocity
between aMCI and AD.
There was no signiﬁcant relationship between gray matter vol-
ume and CVR velocity (c2 ¼ 1.42, p ¼ 0.234) nor between Fazekas
score (representing microangiopathy severity) and CVR velocity
(c2 ¼ 0.23, p ¼ 0.633). There was also no signiﬁcant relationship
between CVR velocity and any of the 12 motion parameters (c2 ¼
0.07e1.51, p ¼ 0.786e0.219 uncorrected).
3.2.2. Lobe-level analysis
In the HC > aMCI contrast on CVR velocities, no lobe passed the
FDR-corrected signiﬁcance threshold, although values were low.
The most different lobe was the occipital lobe (t ¼ 2.21, p ¼ 0.014
uncorrected), whereas the least different was the central lobe (t ¼
1.36, p ¼ 0.087 uncorrected). For the HC > AD contrast, all lobes
except central and the subcortical pseudo-lobe (putamen, caudate,
and thalamus) had signiﬁcantly higher velocities in control subjects
than in patients (p ¼ 0.028 FDR). No signiﬁcant difference in ve-
locity between aMCI and AD was found in the aMCI > AD contrast.
No contrast showed a signiﬁcant difference in CVR amplitude. Fig. 2
(A) shows the distribution of CVR velocity values for all groups and
lobes. Fig. 2 (B) shows the brain space map of the effect size of CVR
velocity in the HC > AD contrast in lobes. Supplementary Table 1
shows the statistics for the 3 contrasts on CVR velocity.
3.2.3. Region-level analysis
Therewere no signiﬁcant pairwise differences in either the HC>
aMCI or HC > AD contrasts on CVR velocity in regions after FDR
correction for multiple comparisons. Four regions had a trend for
differences in the HC > aMCI contrast (p < 0.01 uncorrected) in
superior left occipital gyrus, left cuneus, and orbital part of the
inferior frontal gyrus. Four regions had a trend for differences in the
HC > AD contrast (p < 0.01 uncorrected) in bilateral straight gyri,
right posterior cingulate, and left precuneus. Supporting the hy-
pothesis of regional differences between groups, uncorrected p-
values were generally low (HC > aMCI: median, 0.051 and range,
0.002e0.272; HC > AD: median, 0.048 and range, 0.004e0.441. The
full distribution is shown in Supplementary Table 2 and
Fig. 2. Lobe-level differences in CVR velocity. (A) Distribution of CVR velocity parameter values for HC (green), aMCI (blue), and AD (red) groups in each lobe. The notch indicates the
median, whereas the black dot indicates the mean of the distribution of values, and outliers are not shown. Patients have lower velocities than control subjects, but there is no
difference between aMCI patients and AD patients. (B) Axial view of differences in CVR velocity at the lobe level, in neurologic convention. Lobes are colorized by equivalent z-score
for the p-value of the lobe-wise contrast HC > AD for the difference in CVR velocity. The brightest color (yellow) corresponds to a z-score of 2.34, whereas the darkest color (red)
maps to 0. All lobes except the central and the subcortical pseudo-lobe (shown in gray) show signiﬁcant difference between groups (p ¼ 0.028 FDR). The occipital and frontal lobes
show the largest difference in CVR velocity. Abbreviations: AD, Alzheimer’s disease; aMCI, amnestic mild cognitive impairment; CVR, cerebrovascular reactivity; FDR, false discovery
rate; HC, healthy controls. (For interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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control subjects versus patients (aMCI þ AD) receiver operating
characteristic analysis of CVR velocity in the 88 regions was 0.64
(range, 0.55e0.72; conﬁdence interval lower bound above 0.5 in 35
regions), indicating that the CVR velocity parameter has some
limited diagnostic power, to a various degree depending on the
region. Note these regions do not exhibit signiﬁcant differences
between groups in gray matter density, as shown by the VBM
analysis. No signiﬁcant difference was found in the aMCI > AD
contrast, and uncorrected p-values were generally high (median,
0.524 and range, 0.092e0.857). Regional time courses for the HC >
aMCI and HC > AD contrasts are illustrated in Fig. 3.
3.2.4. Relationship between CVR and cognitive scores
Thirty-ﬁve regions had a signiﬁcant model ﬁt (p ¼ 0.019 FDR;
minimum adjusted R2, 0.12; maximum, 0.25; mean and SD, 0.17 
0.03, corresponding on average to a large effect size) and showed a
signiﬁcant positive relationship betweenMMSE and CVR (p¼ 0.037
FDR), as well as a signiﬁcant negative age MMSE interaction (p ¼
0.038 FDR). Ten regions of the DMN showed a signiﬁcant ﬁt: the left
anterior and posterior cingulates, bilateral precuneus, bilateral
middle frontal gyri, left parietal inferior gyrus, bilateral angular gyri,
and leftmiddle temporal gyrus (themappingbetweendefault-mode
network and the corresponding 26 AAL labels is found in Fransson
and Marrelec, 2008; Richiardi et al., 2012). In the temporal lobe,
only 1 of 14 regionswas signiﬁcant, instead of the expected 6 regionsFig. 3. Illustrative regional time courses in control subjects and patients. Regional time cours
AD), and model predicted response (black). Illustrative regions with the most difference in C
Top row: HC > aMCI, bottom row: HC > AD. (A) Left cuneus (p ¼ 0.007 uncorrected), (B) left
(D) left precuneus (p ¼ 0.007, uncorrected). The insets show an axial view through the mea
noticeably slower than control subjects’ in reaching steady state. Abbreviations: AD, Alzheime
HC, healthy controls. (For interpretation of the references to color in this ﬁgure, the readerif the proportion of signiﬁcant regionswas equal across all lobes. The
baseline model with only age and gender had no signiﬁcant ﬁts,
suggesting that MMSE and age  MMSE interaction are indeed
related to CVR velocity. Supplementary Table 2 shows coefﬁcients of
determination and corresponding F-test p-value for all regional
models. Fig. 4 shows thebrain spacemapof the equivalent z value for
the p-values of the region-level F-test formodelﬁt of CVRvelocity on
MMSE, age, and their interaction, corrected by gender.
In the regions with a signiﬁcant ﬁt, MMSE had a positive rela-
tionship with CVR velocity, and this relationship was modulated by
age. The interaction between age andMMSEwas antagonistic, that is,
the relationshipbetweenMMSEandCVRvelocity is smallerwhenage
is higher. Fig. 5 shows themoderating effect of age on the relationship
betweenMMSE interaction plot for subjects who are at themean age
in our sample (73), as well as 1 standard deviation above (81) and
below (65). Microangiopathy severity was not a signiﬁcant predictor
(over 88 regions; t-statistic range, e0.835 to 2.284; median, 0.461;
uncorrected p-value range, 0.026e0.988; median, 0.629).
4. Discussion
Using a simple and well-tolerated MR imaging paradigm, we
found that the neurocognitive decline in aMCI and AD, as repre-
sented by MMSE score, is paralleled by reduced CVR velocity, and
that this change in velocity is not related to general or focal gray
matter atrophy, microangiopathy, or motion.es for all subjects (gray lines) and their average (green for HC, blue for aMCI, and red for
VR velocity parameter and signiﬁcant average model ﬁt across subjects in both groups.
superior occipital gyrus (p ¼ 0.002 uncorrected), (C) left cuneus (p ¼ 0.01 uncorrected),
n z-coordinate of the corresponding region, highlighted in white. Patients’ response is
r’s disease; aMCI, amnestic mild cognitive impairment; CVR, cerebrovascular reactivity;
is referred to the web version of this article.)
Fig. 4. Relationship between CVR velocity andMMSE score. Axial viewof the relationship between CVR velocity parameter andMMSE score at the regional level, in neurologic convention.
Regions are colorized by equivalent z-score for the p-value of the full cognitivemodelﬁt (comprising age, gender,MMSE, and ageMMSE). The brightest color (yellow) corresponds to a z-
score of 3.44,whereas the darkest color (red)maps to 0. Regionswith insigniﬁcant relationship betweenMMSE and CVR velocity are shown in gray,whereas regionswith an orange-yellow
hueshowasigniﬁcantassociation (p¼0.019FDR).Note, that this relationship isparticularly strong in frontal andoccipital areas,whereas temporalareas showless effect.Abbreviations:CVR,
cerebrovascular reactivity; MMSE, Mini Mental State Examination. (For interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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Decreased CVR velocity is consistent with literature. In a visual
task fMRI experiment, AD patients were shown to have widespread
decreases of early response, corresponding to delayed response to a
stimulus (Rombouts et al., 2005). Velocity decreases have also been
observed in mouse models of AD, with slower return to the normal
diameter of blood vessels after a vasoconstrictive drug was applied
(Rancillac et al., 2012). Although many neurovascular factors may
contribute to the difference between control subjects and patients
in CVR velocity, changes in vessel stiffness would be consistent with
our observations. Sabayan et al. (2012) reported in a meta-analysis
that AD patients have higher pulsatility index (Gosling and King,
1974) in the middle cerebral artery, indicating higher downstream
resistance. Results on pulsewave velocity also suggest stiffer vessels
in AD, which may contribute to our observed velocity differences.
Ten regions of the DMN had a signiﬁcant association between
MMSE and CVR velocity. This is noteworthy because reductions and
desynchronization of the DMN are consistently reported in resting-
state fMRI studies of MCI and AD without CO2 challenge (Barkhof
et al., 2014; Greicius et al., 2004). Such a decrease in functional
connectivity can be explained by a number of factors, one of which
may be regional differences in CVR velocity (itself potentially
modulated by spontaneous respiration rate changes during resting
state; Murphy et al., 2013).
4.2. CVR velocity and cognitive performance
The frontal and occipital lobes are notable because they have
signiﬁcantly lower CVR velocity in patients, and several regions
where lower CVR velocity is associated with lower MMSE scores, awidely used and accepted yet coarse measure of the overall
cognitive status. This agrees with previous studies reporting
abnormal CVR in the frontal lobe of patients (Cantin et al., 2011;
Yezhuvath et al., 2012). Because the amplitude of cerebral blood
ﬂow in the frontal lobe is not signiﬁcantly different between control
subjects and patients under CO2 challenge (Cantin et al., 2011; Oishi
et al., 1999), this velocity difference could be functionally relevant in
cognitive performance. This is consistent with reports of a positive
correlation between CVR amplitude and MMSE score in several
lobes (Cantin et al., 2011) and between CVR amplitude and Boston
Naming Test scores in the frontal lobe (Yezhuvath et al., 2012)
(although that study found no correlation with MMSE). Alterna-
tively, a difference of baseline function could also explain the CVR
velocity difference between groups. For example, MCI can lead to
higher neuronal activationwhen performing simple cognitive tasks
(Kochan et al., 2010). Thus, although the aMCI subjects in our study
canmaintain relatively intact cognitive function (MMSE slightly but
not signiﬁcantly lower than control subjects), their vascular reserve
is already showing signs of depletion, as reﬂected in our results.
Conversely, it has been reported that AD and MCI patients have a
widespread decrease in baseline T2* signal (Rombouts et al., 2007),
although it was ascribed to gray matter atrophy differences which
are mostly insigniﬁcant in our data. The dynamics difference
observed in our results, where cognitive demands are minimal,
could stem from a possible nonlinearity of vessel dilation speeds:
vessel dilation in patients could start from a different baseline
(either higher or lower) than control subjects. Finally, the modu-
latory effect of age on the relationship between MMSE and CVR
velocity can be attributed to several factors, for example, increasing
medication or hypertensionwith age could disrupt the relationship.
Additionally, age-related cholinergic system impairment could
Fig. 5. Age modulates the relationship between CVR velocity and cognitive performance. The relationship between cognitive performance and CVR velocity is modulated by age.
This plot, for the left cuneus, shows that a higher CVR velocity (higher value) corresponds to a higher MMSE score for relatively younger subjects. Subjects in the lowest and highest
5% of MMSE scores were trimmed for display (leaving 60 cases). The left panel shows the relationship if a subject is 68 years old (ﬁrst quartile of the trimmed sample), whereas the
middle and right panel show the relationship if a subject is 72 years old (median) and 79 year old, respectively (third quartile). The gray band shows the 95% conﬁdence interval for
the regression line. The dots indicate partial residuals (conditional on the age in that panel). Abbreviations: CVR, cerebrovascular reactivity; MMSE, Mini Mental State Examination.
(For interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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et al., 2013).
In the absence of established reference methods for in vivo
assessment of cognitive reserve in the workup of cognitive decline,
this study offers an additional vascular parameter, CVR velocity,
which is linked to cognition and could be used in future studies as a
factor to model when examining the cognitive reserve hypothesis,
in addition to more established measures such as blood ﬂow or
structural and/or volumetric features.4.3. CVR dynamics assessment in clinical practice
The clinical protocol used is easy to administer and well-
tolerated by patients with aMCI and mild AD. The simple on-off
“square wave” CO2 stimulus is straightforward to apply and a
robust probe for CVR dynamics (Mutch et al., 2012). Our results
show that a simple nasal cannula is sufﬁcient to induce signiﬁcant
whole-brain BOLD response under CO2 challenge with acceptable
acquisition time, and the setup necessary for the CO2 clinical pro-
tocol does not interfere with the structural MRI typically performed
in routine workup on cognitive decline. The alternative setup
including a tight facemask segregating inﬂow and outﬂow allows
not only more accurate application of CO2 but also assessing expi-
ratory CO2 concentrations and is clearly more accurate in a research
setting. However, there are constraints for the clinical applications,
which should be considered. The experimental setup should be
simple, inexpensive, and easy to use; attributes of the nasal cannula
setup of the current investigation yet not of setups with tight
facemasks requiring additionally devices to apply and measure CO2
as well as compensation of the airﬂow resistance induced by the
facemask. Moreover, a tight facemask setup substantially reduces
patient comfort and in our experience further increased already
present head motion artifacts (Haller et al., 2014). Standard MR
imaging is routinely performed for the workup of neurocognitive
decline in many centers. In our opinion, one of the fundamental
requirements for the CVR assessment in this setting is the minimal
interferencewith this standardMR imaging. Using a tight facemask,
there are 2 options. The ﬁrst option is installing the facemask
during the entire MR imaging, yet this unnecessary reduces the
patient comfort even during anatomic imaging and probably
increases motion artifacts. The other option is installing the face-
mask after structural imaging only before the CVR imaging. Thishowever requires additional installation during MR imaging,
potentially the need to repeat scout scans, thereby prolonging the
total measurement time. In contrast, the nasal cannula is easily and
rapidly installed, does not interfere with anatomic imaging, and
was well tolerated by all participants. Our setup is very simple and
cheap, takes less than aminute to put in place, waswell tolerated by
all participants, did not interfere with standard MRI imaging, and
can with only minimal demands be applied in any MRI center and
clinical routine. The only requirement is the gas bottle with a ready
to use mix of CO2, whereas silicone tubes and nasal canals are
standard equipments in most centers.4.4. Limitations of the study
There were several limitations to this study. First, the relatively
low number of aMCI patients and lack of follow-up could explain not
ﬁnding a differencewith AD patients. Although our results show that
CVR dynamics are also impaired in aMCI patients, it is possible that
changes in aMCI converters are gradual and could not be observed
here. Second, our model cannot distinguish between dilation
(washin) and contraction (washout) velocities because a single
parameter controls both, but it is possible that they are differentially
affected by disease status and progression. Third, our results do not
show a difference in the CVR velocity of the hippocampus or para-
hippocampal formation. This may be because of ﬁeld inhomogeneity
in that region, but literature onhippocampal bloodﬂowdifferences in
dementia is inconclusive; observed differencesmay dependon image
processing choices (Binnewijzend et al., 2013). Fourth, the absence of
differences in the amplitude of CVR between study groups might be
related to the relatively weaker hypercapnic stimuli using a nasal
cannula as compared with a tight facemask. As discussed previously,
simple experimental setup and noninterference with routine struc-
tural MR imaging were fundamental prerequisites for our study
setup. Consequently,wedeliberately took into account the less potent
application of CO2. Fifth, proximal vascular stenosis could potentially
confound the dynamics of the CVR assessment (Haller et al., 2008).
This potential confound could in principle be assessed by adding MR
angiography of the cerebral vessels. Finally, our measure of cognitive
performance,MMSE, encompasses several functional domains:many
functional aspects of cognition are affected by cognitive decline, and it
would be interesting to pinpoint more speciﬁcally which cognitive
domain links with CVR parameters.
J. Richiardi et al. / Neurobiology of Aging 36 (2015) 33e41 414.5. Conclusion
In summary, aMCI and AD patients showed slower CVR response
than control subjects to CO2 BOLD challenge, and CVR response
velocity was related to cognitive performance, modulated by age.
The dynamics of cerebrovascular reactivity could be a useful tool in
the study of the relationship between neurovascular reserve,
cognitive performance, and cognitive reserve. CVR dynamics can be
assessed by a simple and well-tolerated clinical protocol, enabling
use of the technique in a routine clinical setting.
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